Danske Bank’s NeoGenomics NEO Stock Holding History

Danske Bank’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,100	Closed	-$16.2K	–	1562
2024 Q3	$16.2K	Buy	1,100 +100	+10%	+$1.56K	﹤0.01%	1375
2024 Q2	$13.9K	Buy	+1,000	New	+$14.2K	﹤0.01%	1085

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Danske Bank's NEO Position: Q4 2024 in Review

Danske Bank sold out of NeoGenomics (NEO) in Q4 2024, closing a stake of 1,100 shares — an estimated $16.2K sold.

Danske Bank first reported a position in NEO in Q2 2024 and held it in 2 quarters. The position peaked at $16.2K in Q3 2024. 253 funds tracked by Wall St. Rank hold NEO as of Q4 2024.

Danske Bank reported no remaining NeoGenomics position as of Q4 2024 after selling out during the quarter.
Danske Bank sold 1,100 NeoGenomics shares in Q4 2024, an estimated $16.2K.
Danske Bank first reported a position in NeoGenomics in Q2 2024 and held it in 2 quarters.
Danske Bank's NeoGenomics position peaked at $16.2K in Q3 2024.
253 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2024.

Based on Danske Bank's 13F filing for Q4 2024, filed 18 Mar 2026.